AbCellera Biologics Inc. ABCL Other Working Capital
Other Working Capital at other companies
Other financials
Where this comes from
Reported directly by AbCellera Biologics Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherNoncashIncomeExpense.
The official record: AbCellera Biologics Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about AbCellera Biologics Inc.'s other working capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AbCellera Biologics Inc.'s other working capital?
- AbCellera Biologics Inc. (ABCL) reported other working capital of -$2.38M in Q1 2026.
- How has AbCellera Biologics Inc.'s other working capital changed year-over-year?
- AbCellera Biologics Inc.'s other working capital decreased by 7.4% year-over-year, from -$2.21M to -$2.38M.
- What is the long-term trend for AbCellera Biologics Inc.'s other working capital?
- Over 2 years (2021 to 2025), AbCellera Biologics Inc.'s other working capital has grown at a 13.1% compound annual growth rate (CAGR), from $2.6M to $3.33M.
- What does other working capital mean?
- Net change in working capital items not separately classified — a residual balancing item.